A retrospective analysis of the efficacy between dasatinib and nilotinib for chronic myeloid leukemia

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: WU, Chia-Hsuan (Chi-Mei Medical Center, Pharmacy, Tainan, China Taiwan)
  • Co-author(s): Yu-Jou Lin Department of Pharmacy, Chi-Mei Medical Center, Tainan City, Taiwan, Province of China
    Chia-Hsuan Wu
    Hui-Chen Su
  • Abstract:

    Methods

    This is a retrospective study. Patients administered dasatinib or nilotinib from 2012 to 2016 in a medical center in southern Taiwan are included. We analyze the hematological response, molecular response and side effects between patients with dasatinib and nilotinib.

    Results

    There were 10 patients included for analysis. 6 patients..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login